Innovating Works

filtrando por convocatoria: HORIZON-JU-GH-EDCTP3-2022-CALL1-01-04

CTCAN: Clinical Trials Community Africa Network NUVOTEQ (PTY) LTD tramitó un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2022-01 With over 25% of the global disease burden, only 3% of global clinical trials occur in Africa. This disproportion is driven by inadequacies...
2023-05-02 - 2025-10-31 | Financiado
EpiGen Ethiopia: BUILDING SCALABLE PATHOGEN GENOMIC EPIDEMIOLOGY FOR ETHIOPIA STICHTING AMSTERDAM INSTITUTE FOR GLOBAL HEALTH AND DEVELOPMENT tramitó un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2022-01 The 21st century witnesses increased incidence of epidemics (Zika, dengue, Ebola, SARS), with as latest highlight the recent COVID-19. Follo...
2023-06-29 - 2028-05-31 | Financiado
SERCEA: Strengthening Ethics and Responsible conduct of Clinical Trials in East and Sub-Saharan Africa UNIVERSITEIT MAASTRICHT tramitó un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2022-01 The increased number of Clinical Trials taking place in Africa as well as the complexity of Clinical Trials designs require that the countri...
2023-05-17 - 2026-06-30 | Financiado
SNIP-AFRICA: Severe neonatal infection adaptive platform trials in Africa FONDAZIONE PENTA ETS tramitó un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2022-01 SNIP-AFRICA aims to establish a clinical research network and architecture to implement adaptive platform trials in sub-Saharan Africa (SSA)...
2023-06-07 - 2028-06-30 | Financiado
PROMISE-ZERO: Implementation of an upgraded strategy to reach zero HIV transmission by breastfeeding in rural and... UNIVERSITE DE MONTPELLIER tramitó un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2022-01 Most cases of paediatric HIV now occur during the breastfeeding period. Through an EDCTP-2 funded randomized controlled trial in Burkina Fas...
2023-03-02 - 2027-06-30 | Financiado
SEMA ReACT: SEvere MAlaria treatment with Rectal artesunate and Artemisinin-based Combination Therapy [in remote... UNIVERSITEIT ANTWERPEN tramitó un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2022-01 Annually, almost 500,000 children under 5 years die from malaria in Africa. Timely access to effective antimalarial therapies is life saving...
2023-03-07 - 2027-03-31 | Financiado
BREEDIME: Building resilient research ethics, Diagnostics and medicines regulatory capacity during routine and... KAROLINSKA INSTITUTET tramitó un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2022-01 An effective and strong regulatory system for health technologies is critical, especially during epidemics and pandemic situations. The dema...
2023-05-02 - 2026-05-31 | Financiado
GREAT-LIFE: Linking Infectious disease Front-liners’ control Efforts with central public health authorities in T... DANMARKS TEKNISKE UNIVERSITET tramitó un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2022-01 The African Great Lakes region is one of the most densely populated areas in Africa and also one of the areas globally with the highest biod...
2023-06-13 - 2028-06-30 | Financiado
NeuroSolve: Implementation of superior treatment regimen and improved patient pathway for neurocysticercosis in... REVOLUTION WORLDWIDE SRL IMPRESA SOCIALE tramitó un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2022-01 Neurocysticercosis (NCC) is a fatal zoonotic disease following ingestion of eggs of the pork tapeworm, Taenia solium. The eggs develop to la...
2023-04-27 - 2027-04-30 | Financiado
STROGHAT: Stop transmission of gambiense human African trypanosomiasis INSTITUUT VOOR TROPISCHE GENEESKUNDE tramitó un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2022-01 Gambiense human African trypanosomiasis (gHAT) is a neglected tropical disease caused by trypanosome parasites. gHAT is fatal if left untrea...
2023-03-31 - 2028-06-30 | Financiado
Decide-TB: Validation of treatment decision algorithms for childhood tuberculosis at low levels of healthcare i... UNIVERSITE DE BORDEAUX tramitó un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2022-01 Childhood tuberculosis (TB) remains globally underdiagnosed and untreated. In 2022, WHO conditionally recommended the use of treatment decis...
2023-04-01 - 2027-03-31 | Financiado
IMPRIMA: Implementing Primaquine Single Low Dose in Africa UNIVERSITE DE STRASBOURG tramitó un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2022-01 The 2021 World Malaria Report estimates that the number of clinical cases in 2020 was 241 million and the number of deaths was 627,000, an i...
2023-04-01 - 2027-03-31 | Financiado
PANGenS: Pan-Africa network for genomic surveillance of poverty related diseases and emerging pathogens FORSCHUNGSZENTRUM BORSTEL LEIBNIZ LUNGENZENTRUM tramitó un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2022-01 The main aim of the proposed project is to use genomic epidemiology of tuberculosis, malaria and emerging and re-emerging pathogens in Afric...
2023-07-01 - 2027-06-30 | Financiado
eWHORM: Enabling the WHO-Roadmap 2030 UNIVERSITATSKLINIKUM BONN tramitó un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2022-01 We will establish for the first time in NTDs an adaptive clinical trial platform and improve clinical research infrastructure in four SSA co...
2023-04-01 - 2028-03-31 | Financiado
ODIN: Strengthening Environmental Surveillance to Advance Public Health Action LUNDS UNIVERSITET tramitó un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2022-01 The ODIN project aims at strengthening capacity for genomics and bioinformatics database management skills for generating, maintaining, and...
2023-07-01 - 2026-06-30 | Financiado
PDMC Saves Lives: Post-discharge malaria chemoprevention in children with severe anaemia in Benin, Kenya, Malawi and U... INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT tramitó un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2022-01 Background: Young children in sub-Saharan Africa are at high risk of severe anaemia, associated with high mortality. Children who have recen...
2023-07-01 - 2026-12-31 | Financiado
INTEGRATE: The Integrate study : An adaptive platform trial for the development of a new intervention to combat... UNIVERSITE DE BORDEAUX tramitó un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2022-01 Lassa fever (LF) is an acute febrile illness associated with bleeding, organ failure, and shock caused by Lassa virus. LF causes outbreaks i...
2023-07-01 - 2028-06-30 | Financiado